000 02351 a2200661 4500
005 20250517111022.0
264 0 _c20180223
008 201802s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.10983
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGaudio, Eugenio
245 0 0 _aBromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma.
_h[electronic resource]
260 _bOncotarget
_cSep 2016
300 _a58142-58147 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcetanilides
_xpharmacology
650 0 4 _aAdenine
_xanalogs & derivatives
650 0 4 _aAgammaglobulinaemia Tyrosine Kinase
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xpharmacology
650 0 4 _aCell Line, Tumor
650 0 4 _aDrug Synergism
650 0 4 _aEverolimus
_xpharmacology
650 0 4 _aHeterocyclic Compounds, 3-Ring
_xpharmacology
650 0 4 _aHistone Deacetylase Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aHydroxamic Acids
_xpharmacology
650 0 4 _aLymphoma, Large B-Cell, Diffuse
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMice, Inbred NOD
650 0 4 _aMice, SCID
650 0 4 _aMolecular Targeted Therapy
_xmethods
650 0 4 _aPiperidines
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aProtein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aPyrazoles
_xpharmacology
650 0 4 _aPyrimidines
_xpharmacology
650 0 4 _aRituximab
_xpharmacology
650 0 4 _aTOR Serine-Threonine Kinases
_xantagonists & inhibitors
650 0 4 _aVorinostat
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aTarantelli, Chiara
700 1 _aPonzoni, Maurilio
700 1 _aOdore, Elodie
700 1 _aRezai, Keyvan
700 1 _aBernasconi, Elena
700 1 _aCascione, Luciano
700 1 _aRinaldi, Andrea
700 1 _aStathis, Anastasios
700 1 _aRiveiro, Eugenia
700 1 _aCvitkovic, Esteban
700 1 _aZucca, Emanuele
700 1 _aBertoni, Francesco
773 0 _tOncotarget
_gvol. 7
_gno. 36
_gp. 58142-58147
856 4 0 _uhttps://doi.org/10.18632/oncotarget.10983
_zAvailable from publisher's website
999 _c26300926
_d26300926